Hantavirus
New hantavirus study results from , Finland and the People's Republic of China described
Published in Medical Letter on the CDC and FDA, December 24th, 2006
Study 1: New research, "The pathogenic NY-1 hantavirus G1 cytoplasmic tail inhibits RIG-I- and TBK-1-directed interferon responses," is the subject of a report. According to a study from the United States, "Hantaviruses cause two diseases with prominent vascular permeability defects, hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome. All hantaviruses infect human endothelial cells, although it is unclear what differentiates pathogenic from nonpathogenic hantaviruses."
"We observed dramatic differences in interferon-specific...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Breast Implants
U.S. FDA approves silicone gel-filled breast implants after in-depth evaluation - Obstetrics
Teen births drop to lowest level ever - Asthma
Pharmaxis reports Phase III results for Aridol as asthma test - Avian Influenza
Novartis secures contract to supply additional H5N1 bird flu vaccine - Breast Cancer
U.S. FDA approves Herceptin for adjuvant treatment of HER2-positive node-positive breast cancer - Breast Implants
Women's research center president faults U.S. FDA decision to allow silicone breast implants - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
